Regional GM

Unframe is seeking a Regional GM to land our first major customers and shape our GTM motion. You’ll partner with the VP of Sales and founders to build a high-performance revenue engine and drive ARR growth in enterprise accounts. You’ll lead multi-stakeholder deals in regulated industries, translate AI/ML capabilities into business value for CIOs, and...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...

Commissioning Engineer for MV Switchboards The Regional Service Representative for Medium Voltage provides professional on-site services for Schneider Electric medium-voltage power distribution solutions, including commissioning, technical diagnostics, and resolution of customer issues. The role primarily supports complex and critical projects, delivering...

Country Manager, ItalyLe informazioni riportate di seguito illustrano i requisiti del ruolo, l'esperienza richiesta ai candidati e le qualifiche associate.Azienda : Notion Tipo Lavoro : Full Time Italy JobCopilot will tailor your resume and auto-fill the application Descrizione Lavoro - Country Manager, ItalyWho We AreNotion is the collaborative AI workspace...

Unframe is an AI-first startup helping the world’s largest enterprises bring LLM-powered applications to life in days - not months. We combine the speed of a product company with the flexibility of a consultancy, helping customers move from idea to deployed AI systems faster than anyone else in the market. With over $100M in TCV secured within 12 months,...

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor;...